Skip to main content
HUONS CO., LTD. logo

HUONS CO., LTD. — Investor Relations & Filings

Ticker · 243070 ISIN · KR7243070000 KO Manufacturing
Filings indexed 385 across all filing types
Latest filing 2022-12-14 Notice of Dividend Amou…
Country KR South Korea
Listing KO 243070

About HUONS CO., LTD.

https://www.huons.com/en

HUONS CO., LTD. is an integrated pharmaceutical and healthcare company founded in 1965. The company develops and manufactures a wide range of finished pharmaceutical products, medical solutions, and medical devices under cGMP standards. It was a pioneer in its domestic market, developing the first plastic ampule injections and local anesthetics. The company's research and development efforts focus on key therapeutic areas including ophthalmology, osteoarthritis, dermatology, wellness, and Central Nervous System (CNS) disorders. Its diversified portfolio also extends to bio products, eye drops, cosmetics, and health functional foods, aiming to provide comprehensive healthcare solutions.

Recent filings

Filing Released Lang Actions
수시공시의무관련사항(공정공시)
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Huons regarding their cash dividend plan for the 2022 fiscal year. It specifies the dividend amount per share, total dividend amount, and the record date. This fits the definition of a 'Notice of Dividend Amount' (DIV) as it provides specific details regarding dividend payments to shareholders.
2022-12-14 Korean
투자판단관련주요경영사항(복합점안제(HU007) 3상 시험계획(IND) 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure from Huons regarding the approval of a Phase 3 clinical trial (IND) for a complex eye drop product (HU007) by the Ministry of Food and Drug Safety (MFDS). It is a specific corporate announcement regarding a material business event (clinical trial progress). Since it does not fit into specific categories like M&A, dividends, or financial reports, and is a formal regulatory disclosure filed with the exchange (KIND), it is classified as a Regulatory Filing (RNS).
2022-11-30 Korean
신규시설투자등(자율공시)
Regulatory Filings Classification · 100% confidence The document is a regulatory disclosure regarding a new facility investment (capital expenditure) by Huons. It details the investment amount, purpose (production line expansion), and timeline. This type of disclosure regarding capital investment and infrastructure expansion falls under the category of 'Capital/Financing Update' (CAP) as it relates to the company's capital allocation and investment activities.
2022-11-28 Korean
투자판단관련주요경영사항(복합점안제(HU007) 독일 임상시험 자진 중단 결정)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Huons regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically announcing the voluntary discontinuation of a Phase III clinical trial in Germany for their eye drop product (HU007). This type of disclosure regarding clinical trial status and strategic business decisions falls under general regulatory announcements for material events, which is best categorized as RNS (Regulatory Filings) as it does not fit into specific categories like M&A, dividends, or financial reports.
2022-11-22 Korean
분기보고서 (2022.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company 'Huons' (주식회사 휴온스) covering the period from January 1, 2022, to September 30, 2022. It contains detailed financial information, business operations, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2022
2022-11-14 Korean
전환사채(해외전환사채포함)발행후만기전사채취득
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Huons regarding the acquisition of convertible bonds before maturity (early redemption). It details the bond series, acquisition amount, reason (exercise of put option by bondholders), and method of cancellation. This falls under capital structure changes and financing updates, specifically related to debt instruments.
2022-11-14 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.